121 related articles for article (PubMed ID: 8674957)
1. [Observation of an increase in "aggressive tumor forms" in increasing incidence of breast carcinoma].
Engelhardt C; Sauerland C; Bettges G
Geburtshilfe Frauenheilkd; 1996 Mar; 56(3):124-7. PubMed ID: 8674957
[TBL] [Abstract][Full Text] [Related]
2. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
[TBL] [Abstract][Full Text] [Related]
3. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
4. Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series.
Viale G; Rotmensz N; Maisonneuve P; Orvieto E; Maiorano E; Galimberti V; Luini A; Colleoni M; Goldhirsch A; Coates AS
Breast Cancer Res Treat; 2009 Sep; 117(1):211-4. PubMed ID: 18629634
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
[TBL] [Abstract][Full Text] [Related]
7. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
Skowronek J; Piotrowski T
Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
[TBL] [Abstract][Full Text] [Related]
8. Management of in situ carcinoma of the breast: lobular and ductal origin.
White RE; Bland KI
R I Med; 1995 Sep; 78(9):242-5. PubMed ID: 7579718
[No Abstract] [Full Text] [Related]
9. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
[TBL] [Abstract][Full Text] [Related]
10. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ
Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features and prognostic factors of small breast cancer with multiple axillary lymph node metastasis].
Liao YQ; Xu BH
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):615-8. PubMed ID: 18210884
[TBL] [Abstract][Full Text] [Related]
12. The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas.
Mylona E; Giannopoulou I; Fasomytakis E; Nomikos A; Magkou C; Bakarakos P; Nakopoulou L
Hum Pathol; 2008 Jul; 39(7):1096-102. PubMed ID: 18495204
[TBL] [Abstract][Full Text] [Related]
13. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer.
Tan YY; Wu CT; Fan YG; Hwang S; Ewing C; Lane K; Esserman L; Lu Y; Treseler P; Morita E; Leong SP
Breast J; 2005; 11(5):338-43. PubMed ID: 16174155
[TBL] [Abstract][Full Text] [Related]
14. Nottingham grades of lobular carcinoma lack the prognostic implications they bear for ductal carcinoma.
Wachtel MS; Halldorsson A; Dissanaike S
J Surg Res; 2011 Mar; 166(1):19-27. PubMed ID: 20828724
[TBL] [Abstract][Full Text] [Related]
15. Results of conservative surgery for limited-sized infiltrating breast cancer: analysis of 962 tested patients: 24 years of experience.
Vitucci C; Tirelli C; Graziano F; Santoro E
J Surg Oncol; 2000 Jun; 74(2):108-15. PubMed ID: 10914819
[TBL] [Abstract][Full Text] [Related]
16. [Bilateral breast carcinoma. 12 years' experience].
Maculotti L; Gandini F; Pradella P
Minerva Chir; 1996; 51(1-2):33-7. PubMed ID: 8677043
[TBL] [Abstract][Full Text] [Related]
17. [A comparative study of metastatic patterns of ductal and lobular carcinoma of the breast from two matched series (376 patients)].
Fondrinier E; Guérin O; Lorimier G
Bull Cancer; 1997 Dec; 84(12):1101-7. PubMed ID: 9587361
[TBL] [Abstract][Full Text] [Related]
18. [The prognosis of bilateral breast carcinoma compared to unilateral breast tumor. 5- and 10-year follow-ups].
Mose S; Adamietz IA; Thilmann C; Saran F; Pahnke R; Böttcher HD
Strahlenther Onkol; 1995 Apr; 171(4):207-13. PubMed ID: 7740408
[TBL] [Abstract][Full Text] [Related]
19. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer.
Katz A; Smith BL; Golshan M; Niemierko A; Kobayashi W; Raad RA; Kelada A; Rizk L; Wong JS; Bellon JR; Gadd M; Specht M; Taghian AG
J Clin Oncol; 2008 May; 26(13):2093-8. PubMed ID: 18445838
[TBL] [Abstract][Full Text] [Related]
20. ABC of breast diseases: breast cancer.
Sainsbury JR; Anderson TJ; Morgan DA
BMJ; 2000 Sep; 321(7263):745-50. PubMed ID: 10999911
[No Abstract] [Full Text] [Related]
[Next] [New Search]